Damae Medical
French tech company | Builders Republic
About
Medtech company building a non-invasive skin-imaging device for dermatologists — its deepLive system uses a proprietary optical technology to produce real-time cellular-level 3D images of the skin, with AI software helping diagnose skin cancers such as melanoma and basal cell carcinoma without a biopsy.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series B
- Founded
- 2014
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 2
- Amount raised
- 20 M€ raised since 2020
Funding rounds
- Series B — 2025
- Series A — 2022
Investors
- BNP Paribas Développement
- Creadev
- Eit Digital Accelerator
- Eurazeo
- ISPB
- Kurma Partners
- Newinvest
- Partech